Spots Global Cancer Trial Database for standard of care chemotherapy
Every month we try and update this database with for standard of care chemotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels | NCT04931420 | Metastatic Canc... Foregut Carcino... Gastric Adenoca... Gallbladder Ade... Liver Cancer GI Cancer GI Carcinoma Lung Cancer | Standard of Car... Video-Assisted ... Lobectomy Consolidative R... Ablation Treatm... Resection or Ex... Peritonectomy Transarterial R... | 18 Years - | University of Chicago | |
| Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC | NCT04648033 | Locally Advance... | Atovaquone Oral... Standard of car... Standard of car... | 18 Years - | University of Oxford | |
| Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC | NCT04648033 | Locally Advance... | Atovaquone Oral... Standard of car... Standard of car... | 18 Years - | University of Oxford | |
| Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas | NCT04620187 | Salivary Gland ... HER2 Gene Mutat... | Ado-trastuzumab... Standard of Car... Standard of Car... | 18 Years - | Dana-Farber Cancer Institute | |
| A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer | NCT01505530 | Pancreatic Canc... | LY2495655 Placebo Standard of Car... | 18 Years - | Eli Lilly and Company | |
| Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma | NCT06044311 | Adenocarcinoma ... Locally Advance... Siewert Type I ... Siewert Type II... | Vactosertib Standard of Car... Concurrent Radi... | 18 Years - | Case Comprehensive Cancer Center | |
| Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas | NCT04620187 | Salivary Gland ... HER2 Gene Mutat... | Ado-trastuzumab... Standard of Car... Standard of Car... | 18 Years - | Dana-Farber Cancer Institute | |
| Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer | NCT02470468 | Stage IV Non-sm... | DCVAC add on to... DCVAC and immun... Standard of Car... | 18 Years - | Sotio Biotech Inc. | |
| A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer | NCT04432207 | Non Small Cell ... Non Small Cell ... Non-small Cell ... Squamous Non-sm... Large Cell Carc... Adenocarcinoma ... | IMU-201 (admini... IMU-201 (admini... IMU-201 (admini... Atezolizumab Standard of car... | 18 Years - | Imugene Limited | |
| Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer | NCT02470468 | Stage IV Non-sm... | DCVAC add on to... DCVAC and immun... Standard of Car... | 18 Years - | Sotio Biotech Inc. | |
| A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer | NCT01505530 | Pancreatic Canc... | LY2495655 Placebo Standard of Car... | 18 Years - | Eli Lilly and Company | |
| Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer | NCT02470468 | Stage IV Non-sm... | DCVAC add on to... DCVAC and immun... Standard of Car... | 18 Years - | Sotio Biotech Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
